PC1244 is a novel potent and long acting antifungal triazole designed for delivery by the inhaled route of administration for the treatment of pulmonary aspergillosis and other difficult to treat fungi. PC1244 exhibits excellent antifungal activity against azole resistant forms of Aspergillus Fumigatus.